XT

Xilio Therapeutics

XLO
NASDAQHealth Care

Income Statement

Total Revenue$9.27M
Operating Income$0
EBITDA$0
EBIT$-56.96M
Pre-tax Income$-54.3M
Net Income$-54.3M

Balance Sheet

Cash Equivalent$89.07M
Total Debt$0
Book Value$17.6
Book Value Per Share0.38

Key Ratios

Return on Equity (ROE)-330.95%
Return on Assets (ROA)-81.94%
Return on Invested Capital (ROI)-330.95%
Net Profit Margin-918.05%
Current Ratio2.21
Quick Ratio2.03
Long-Term Debt / Equity0.00